Clinical trial

Study to Evaluate the Pharmacokinetic (PK) Interactions Between GSK3640254 and Dolutegravir (DTG)

NCT03816696

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-01-23

PhasePHASE1

Study timeline

Study start (actual)2019-01-23Date precision: day

Registry last updated2020-03-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

GSK3640254DRUG

DTGDRUG

Sponsors & collaborators

ViiV Healthcarelead sponsor

Mapped research locations

AustinTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03816696 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.